Research Synthesis, HIV Prevention Response, and Public Health: CDC's HIV/AIDS Prevention Research Synthesis Project.

Linda J Koenig, Cynthia M Lyles, Darrel Higa, Mary M Mullins, Theresa A Sipe
Author Information
  1. Linda J Koenig: Prevention Research Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. ORCID
  2. Cynthia M Lyles: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  3. Darrel Higa: Prevention Research Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  4. Mary M Mullins: Prevention Research Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  5. Theresa A Sipe: Prevention Research Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

OBJECTIVE: Research synthesis, through qualitative or quantitative systematic reviews, allows for integrating results of primary research to improve public health. We examined more than 2 decades of work in HIV prevention by the Centers for Disease Control and Prevention's (CDC's) HIV/AIDS Prevention Research Synthesis (PRS) Project. We describe the context and contributions of research synthesis, including systematic reviews and meta-analyses, through the experience of the PRS Project.
METHODS: We reviewed PRS Project publications and products and summarized PRS contributions from 1996 to July 2020 in 4 areas: synthesis of interventions and epidemiologic studies, synthesis methods, prevention programs, and prevention policy.
RESULTS: PRS Project publications summarized risk behaviors and effects of prevention interventions (eg, changing one's perception of risk, teaching condom negotiation skills) across populations at risk for HIV infection and intervention approaches (eg, one-on-one or group meetings) as the HIV/AIDS epidemic and science evolved. We used the PRS Project cumulative database and intervention efficacy reviews to contribute to prevention programs and policies through identification of evidence-based interventions and development of program guidance. Subject matter experts and scientific evidence informed PRS Project products and contributions, which were implemented through strategic programmatic partnerships.
CONCLUSIONS: The contributions of the PRS Project to HIV prevention and public health efforts in the United States can be credited to CDC's long-standing support of the project and its context within a federal prevention agency, where HIV programs and policies were developed and implemented. The effect of the PRS Project was likely facilitated by opportunities to directly influence program and policy because of connections with other research translation activities and program and policy decision making within CDC.

Keywords

References

  1. PLoS One. 2014 May 19;9(5):e97596 [PMID: 24840662]
  2. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S130-3 [PMID: 12107366]
  3. J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):446-453 [PMID: 27391389]
  4. AIDS Behav. 2013 May;17(4):1231-44 [PMID: 23397183]
  5. Am J Prev Med. 2016 Jun;50(6):699-708 [PMID: 26947213]
  6. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S73-93 [PMID: 12107362]
  7. AIDS Educ Prev. 2006 Aug;18(4 Suppl A):5-20 [PMID: 16987085]
  8. Am J Public Health. 2009 Sep;99(9):1576-83 [PMID: 19608941]
  9. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;66(31):830-832 [PMID: 28796758]
  10. AIDS Behav. 2017 Dec;21(12):3366-3430 [PMID: 29159594]
  11. AIDS Educ Prev. 2006 Aug;18(4 Suppl A):21-31 [PMID: 16987086]
  12. Res Synth Methods. 2014 Jun;5(2):116-30 [PMID: 26052651]
  13. Res Synth Methods. 2015 Sep;6(3):268-71 [PMID: 26097220]
  14. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  15. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S118-29 [PMID: 12107365]
  16. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S30-50 [PMID: 12107358]
  17. AIDS. 2014 Mar 13;28(5):633-56 [PMID: 24983541]
  18. MMWR Morb Mortal Wkly Rep. 2006 Jun 2;55(21):597-603 [PMID: 16741496]
  19. AIDS Patient Care STDS. 2019 Dec;33(12):528-537 [PMID: 31750731]
  20. AIDS Educ Prev. 2005 Oct;17(5):405-17 [PMID: 16255637]
  21. AIDS Educ Prev. 2020 Feb;32(1):1-S7 [PMID: 32073309]
  22. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S94-S105 [PMID: 12107363]
  23. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S134-6 [PMID: 12107367]
  24. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  25. Res Synth Methods. 2015 Sep;6(3):221-31 [PMID: 26355796]
  26. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S15-29 [PMID: 12107357]
  27. AIDS. 2006 Jan 9;20(2):143-57 [PMID: 16511407]
  28. AIDS Behav. 2018 Jan;22(1):43-63 [PMID: 28983684]
  29. AIDS Care. 2019 Nov;31(11):1323-1331 [PMID: 30773038]
  30. Sex Transm Dis. 2007 Jun;34(6):319-32 [PMID: 17038965]
  31. AIDS Behav. 2007 Jan;11(1):25-47 [PMID: 16917668]
  32. AIDS Behav. 2014 Apr;18(4):646-60 [PMID: 24043269]
  33. PLoS One. 2015 Jul 27;10(7):e0133543 [PMID: 26214309]
  34. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):379-386 [PMID: 32205721]
  35. Am J Public Health. 2009 Nov;99(11):2069-78 [PMID: 19762676]
  36. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S62-72 [PMID: 12107361]
  37. Am J Public Health. 2004 Mar;94(3):361-6 [PMID: 14998794]
  38. Health Care Manag Sci. 2011 Mar;14(1):115-24 [PMID: 21184183]
  39. AIDS Educ Prev. 2011 Dec;23(6):479-94 [PMID: 22201233]
  40. Health Psychol. 2018 Jun;37(6):574-585 [PMID: 29781655]
  41. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S8-S14 [PMID: 12107356]
  42. AIDS. 2008 Jun 19;22(10):1177-94 [PMID: 18525264]
  43. AIDS. 2000 Jun 16;14(9):1257-68 [PMID: 10894291]
  44. Am J Community Psychol. 2012 Dec;50(3-4):518-29 [PMID: 22684737]
  45. J Int Assoc Provid AIDS Care. 2015 Nov-Dec;14 Suppl 1:S3-S34 [PMID: 26527218]
  46. Eval Health Prof. 2002 Mar;25(1):12-37 [PMID: 11868442]
  47. N Engl J Med. 2005 Dec 1;353(22):2397-402 [PMID: 16319391]
  48. Public Health Rep. 2018 Jan/Feb;133(1):3-21 [PMID: 29182894]
  49. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S106-17 [PMID: 12107364]
  50. Lancet. 2015 Aug 8;386(9993):505-7 [PMID: 26293427]
  51. AIDS. 2006 Jun 26;20(10):1447-50 [PMID: 16791020]
  52. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S51-5 [PMID: 12107359]
  53. AIDS. 2018 Nov 13;32(17):2633-2635 [PMID: 30096073]
  54. AIDS Educ Prev. 2004 Aug;16(4):341-52 [PMID: 15342336]
  55. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S1-7 [PMID: 12107355]
  56. AIDS. 2015 Nov 28;29(18):2371-83 [PMID: 26372483]
  57. Am J Public Health. 2014 Nov;104(11):e110-7 [PMID: 25211744]
  58. AIDS Educ Prev. 2000;12(5 Suppl):35-48 [PMID: 11063068]
  59. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):228-41 [PMID: 15905741]
  60. PLoS Med. 2007 Sep;4(9):e275 [PMID: 17880259]
  61. J Acquir Immune Defic Syndr. 2002 Jul 1;30 Suppl 1:S56-61 [PMID: 12107360]
  62. AIDS Behav. 2012 Aug;16(6):1394-410 [PMID: 22323004]
  63. AIDS Behav. 2017 Oct;21(10):2835-2843 [PMID: 28573378]
  64. Am J Prev Med. 2016 Oct;51(4 Suppl 2):S140-7 [PMID: 27402185]
  65. AIDS Educ Prev. 2005 Dec;17(6):568-89 [PMID: 16398578]
  66. AIDS Behav. 2016 May;20(5):951-66 [PMID: 26404014]
  67. AIDS Behav. 2013 Jul;17(6):1941-62 [PMID: 23456593]
  68. Am J Prev Med. 2007 Apr;32(4 Suppl):S38-67 [PMID: 17386336]
  69. AIDS Behav. 2019 Sep;23(9):2226-2237 [PMID: 30798460]
  70. Ann Intern Med. 2012 Jun 5;156(11):817-33, W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, [PMID: 22393036]
  71. Psychol Bull. 1995 Jan;117(1):167-78 [PMID: 7870860]
  72. Curr HIV/AIDS Rep. 2012 Dec;9(4):313-25 [PMID: 22996171]
  73. Epidemiol Rev. 2012;34:103-19 [PMID: 22128086]
  74. Open AIDS J. 2012;6:98-107 [PMID: 23049658]
  75. Sex Transm Dis. 2006 May;33(5):320-8 [PMID: 16505750]
  76. Res Synth Methods. 2015 Sep;6(3):284-6 [PMID: 26097046]
  77. AIDS Behav. 2011 Oct;15(7):1283-97 [PMID: 20886277]
  78. Open AIDS J. 2012;6:26-8 [PMID: 22496716]
  79. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230 [PMID: 18646068]
  80. J Public Health Manag Pract. 2016 Nov-Dec;22(6):567-75 [PMID: 26352385]
  81. Am J Epidemiol. 2005 Nov 15;162(10):1032; author reply 1033 [PMID: 16207806]
  82. BMJ Open. 2012 Dec 19;2(6): [PMID: 23257774]
  83. AIDS Behav. 2013 Jul;17(6):1963-78 [PMID: 23386132]
  84. Am J Prev Med. 2012 Mar;42(3):272-94 [PMID: 22341164]
  85. Res Synth Methods. 2010 Jan;1(1):39-65 [PMID: 26056092]
  86. Health Psychol. 2008 Jan;27(1):4-14 [PMID: 18230008]
  87. AIDS Behav. 2012 Jul;16(5):1092-114 [PMID: 22234436]
  88. BMJ. 2007 Aug 4;335(7613):248 [PMID: 17656503]
  89. AIDS Behav. 2015 Sep;19(9):1701-19 [PMID: 25711295]
  90. Am J Public Health. 2007 Jan;97(1):133-43 [PMID: 17138920]
  91. AIDS. 2018 Nov 13;32(17):2557-2571 [PMID: 30102661]
  92. J Int AIDS Soc. 2016 Feb 23;19(1):20627 [PMID: 26928810]
  93. Res Synth Methods. 2015 Sep;6(3):246-64 [PMID: 26212600]
  94. Focus. 2007 Oct;22(7):1-5 [PMID: 18333628]
  95. Res Synth Methods. 2015 Mar;6(1):2-20 [PMID: 26035466]
  96. Am J Public Health. 2019 Jan;109(1):e1-e8 [PMID: 30496000]
  97. AIDS Care. 2015;27(11):1361-6 [PMID: 26608175]
  98. AIDS Educ Prev. 2019 Dec;31(6):505-522 [PMID: 31815530]
  99. Drug Alcohol Depend. 2017 May 1;174:47-57 [PMID: 28314193]
  100. Cochrane Database Syst Rev. 2003;(1):CD001230 [PMID: 12535405]

MeSH Term

Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, U.S.
Epidemiologic Studies
HIV Infections
Humans
Policy
Primary Prevention
Public Health
Research
Research Design
United States

Word Cloud

Created with Highcharts 10.0.0ProjectPRSpreventionHIVResearchsynthesisreviewsHIV/AIDSPreventionSynthesiscontributionssystematicresearchCDC'sinterventionsprogramspolicyriskprogrampublichealthcontextpublicationsproductssummarizedeginterventionpoliciesimplementedwithinOBJECTIVE:qualitativequantitativeallowsintegratingresultsprimaryimproveexamined2decadesworkCentersDiseaseControlPrevention'sdescribeincludingmeta-analysesexperienceMETHODS:reviewed1996July20204areas:epidemiologicstudiesmethodsRESULTS:behaviorseffectschangingone'sperceptionteachingcondomnegotiationskillsacrosspopulationsinfectionapproachesone-on-onegroupmeetingsepidemicscienceevolvedusedcumulativedatabaseefficacycontributeidentificationevidence-baseddevelopmentguidanceSubjectmatterexpertsscientificevidenceinformedstrategicprogrammaticpartnershipsCONCLUSIONS:effortsUnitedStatescancreditedlong-standingsupportprojectfederalagencydevelopedeffectlikelyfacilitatedopportunitiesdirectlyinfluenceconnectionstranslationactivitiesdecisionmakingCDCResponsePublicHealth:meta-analysis

Similar Articles

Cited By